Get it on Google Play

Insilico Medicine wins FDA fast track for mesothelioma drug ISM6331

July 29, 2026 8:30 AM EDT Send to a Friend
Insilico Medicine (HKEX: 3696) announced that its pan-TEAD inhibitor ISM6331 has received Fast Track Designation (FTD) from the U.S. Food ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login